Qube Research & Technologies (QRT)’s Theravance Biopharma TBPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.31M	Buy	429,813 +140,340	+48%	+$2.32M	0.01%	1445
2026 Q1	$4.7M	Sell	289,473 -184,025	-39%	-$3.26M	0.01%	1688
2025 Q4	$8.86M	Buy	473,498 +262,450	+124%	+$4.35M	0.01%	1425
2025 Q3	$3.08M	Buy	211,048 +5,768	+3%	+$72.9K	﹤0.01%	2010
2025 Q2	$2.26M	Buy	205,280 +91,341	+80%	+$888K	﹤0.01%	2152
2025 Q1	$1.02M	Buy	+113,939	New	+$1.06M	﹤0.01%	2253
2020 Q4	–	Sell	-17,094	Closed	-$253K	–	2189
2020 Q3	$253K	Buy	17,094 +3,971	+30%	+$74.4K	﹤0.01%	1312
2020 Q2	$275K	Buy	+13,123	New	+$337K	﹤0.01%	1339

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TBPH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Theravance Biopharma (TBPH) stake by 48% in Q2 2026, buying an estimated $2.32M and bringing the position to 429,813 shares worth $7.31M. The position accounts for 0.01% of the portfolio, ranked #1445.

Qube Research & Technologies (QRT) first reported a position in TBPH in Q2 2020 and has held it in 8 quarters since. The position peaked at $8.86M in Q4 2025. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Qube Research & Technologies (QRT) held 429,813 shares of Theravance Biopharma worth $7.31M as of Q2 2026.
Qube Research & Technologies (QRT) bought 140,340 Theravance Biopharma shares in Q2 2026, an estimated $2.32M.
Theravance Biopharma made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1445 holding.
Qube Research & Technologies (QRT) first reported a position in Theravance Biopharma in Q2 2020 and has held it in 8 quarters since.
Qube Research & Technologies (QRT)'s Theravance Biopharma position peaked at $8.86M in Q4 2025.
181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.